125 related articles for article (PubMed ID: 18175333)
1. Platelet receptor P2RY12 haplotypes predict restenosis after percutaneous coronary interventions.
Rudez G; Pons D; Leebeek F; Monraats P; Schrevel M; Zwinderman A; de Winter R; Tio R; Doevendans P; Jukema W; de Maat M
Hum Mutat; 2008 Mar; 29(3):375-80. PubMed ID: 18175333
[TBL] [Abstract][Full Text] [Related]
2. Common variation in the platelet receptor P2RY12 gene is associated with residual on-clopidogrel platelet reactivity in patients undergoing elective percutaneous coronary interventions.
Rudez G; Bouman HJ; van Werkum JW; Leebeek FW; Kruit A; Ruven HJ; ten Berg JM; de Maat MP; Hackeng CM
Circ Cardiovasc Genet; 2009 Oct; 2(5):515-21. PubMed ID: 20031628
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention.
Monraats PS; Fang Y; Pons D; Pires NM; Pols HA; Zwinderman AH; de Maat MP; Doevendans PA; DeWinter RJ; Tio RA; Waltenberger J; Frants RR; Quax PH; van der Laarse A; van der Wall EE; Uitterlinden AG; Jukema JW
Expert Opin Ther Targets; 2010 Mar; 14(3):243-51. PubMed ID: 20095921
[TBL] [Abstract][Full Text] [Related]
4. Genetic inflammatory factors predict restenosis after percutaneous coronary interventions.
Monraats PS; Pires NM; Agema WR; Zwinderman AH; Schepers A; de Maat MP; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Frants RR; Quax PH; van Vlijmen BJ; Atsma DE; van der Laarse A; van der Wall EE; Jukema JW
Circulation; 2005 Oct; 112(16):2417-25. PubMed ID: 16230497
[TBL] [Abstract][Full Text] [Related]
5. Association between platelet P2Y12 haplotype and risk of cardiovascular events in chronic coronary disease.
Schettert IT; Pereira AC; Lopes NH; Hueb WA; Krieger JE
Thromb Res; 2006; 118(6):679-83. PubMed ID: 16405973
[TBL] [Abstract][Full Text] [Related]
6. The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions.
Pons D; Monraats PS; de Maat MP; Pires NM; Quax PH; van Vlijmen BJ; Rosendaal FR; Zwinderman AH; Doevendans PA; Waltenberger J; de Winter RJ; Tio RA; Frants RR; van der Laarse A; van der Wall EE; Jukema JW
Thromb Haemost; 2007 Dec; 98(6):1323-8. PubMed ID: 18064331
[TBL] [Abstract][Full Text] [Related]
7. Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease.
Cavallari U; Trabetti E; Malerba G; Biscuola M; Girelli D; Olivieri O; Martinelli N; Angiolillo DJ; Corrocher R; Pignatti PF
BMC Med Genet; 2007 Sep; 8():59. PubMed ID: 17803810
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention.
Monraats PS; Kurreeman FA; Pons D; Sewgobind VD; de Vries FR; Zwinderman AH; de Maat MP; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Huizinga TW; Eefting D; Quax PH; Frants RR; van der Laarse A; van der Wall EE; Jukema JW
Genes Immun; 2007 Jan; 8(1):44-50. PubMed ID: 17122782
[TBL] [Abstract][Full Text] [Related]
9. p27kip1-838C>A single nucleotide polymorphism is associated with restenosis risk after coronary stenting and modulates p27kip1 promoter activity.
van Tiel CM; Bonta PI; Rittersma SZ; Beijk MA; Bradley EJ; Klous AM; Koch KT; Baas F; Jukema JW; Pons D; Sampietro ML; Pannekoek H; de Winter RJ; de Vries CJ
Circulation; 2009 Aug; 120(8):669-76. PubMed ID: 19667240
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary intervention.
Beijk MA; Boekholdt SM; Rittersma SZ; Pons D; Zwinderman AH; Doevendans PA; Tio RA; Tijssen JG; Jukema JW; de Winter RJ
Pharmacogenet Genomics; 2010 Sep; 20(9):544-52. PubMed ID: 20671584
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein lipase gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention.
Monraats PS; Rana JS; Nierman MC; Pires NM; Zwinderman AH; Kastelein JJ; Kuivenhoven JA; de Maat MP; Rittersma SZ; Schepers A; Doevendans PA; de Winter RJ; Tio RA; Frants RR; Quax PH; van der Laarse A; van der Wall EE; Jukema JW
J Am Coll Cardiol; 2005 Sep; 46(6):1093-100. PubMed ID: 16168296
[TBL] [Abstract][Full Text] [Related]
12. The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor.
Bouman HJ; van Werkum JW; Rudez G; Leebeek FW; Kruit A; Hackeng CM; Ten Berg JM; de Maat MP; Ruven HJ
Thromb Haemost; 2010 Feb; 103(2):379-86. PubMed ID: 20126830
[TBL] [Abstract][Full Text] [Related]
13. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects.
Fontana P; Dupont A; Gandrille S; Bachelot-Loza C; Reny JL; Aiach M; Gaussem P
Circulation; 2003 Aug; 108(8):989-95. PubMed ID: 12912815
[TBL] [Abstract][Full Text] [Related]
14. [Genetic variants of platelet ADP receptor P2Y12 associated with changed platelet functional activity and development of cardiovascular diseases].
Sirotkina OV; Zabotina AM; Berkovich OA; Bazhenova EA; Vavilova TV; Shvartsman AL
Genetika; 2009 Feb; 45(2):247-53. PubMed ID: 19334620
[TBL] [Abstract][Full Text] [Related]
15. Inflammation and apoptosis genes and the risk of restenosis after percutaneous coronary intervention.
Monraats PS; de Vries F; de Jong LW; Pons D; Sewgobind VD; Zwinderman AH; de Maat MP; 't Hart LM; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Frants RR; van der Laarse A; van der Wall EE; Wouter Jukema J
Pharmacogenet Genomics; 2006 Oct; 16(10):747-54. PubMed ID: 17001294
[TBL] [Abstract][Full Text] [Related]
16. Fractalkine receptor polymorphisms V2491 and T280M as genetic risk factors for restenosis.
Niessner A; Marculescu R; Kvakan H; Haschemi A; Endler G; Weyand CM; Maurer G; Mannhalter C; Wojta J; Wagner O; Huber K
Thromb Haemost; 2005 Dec; 94(6):1251-6. PubMed ID: 16411402
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived chemokine RANTES may be a sign of restenosis after percutaneous coronary intervention in patients with stable angina pectoris.
Inami N; Nomura S; Manabe K; Kimura Y; Iwasaka T
Platelets; 2006 Dec; 17(8):565-70. PubMed ID: 17127484
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha plays an important role in restenosis development.
Monraats PS; Pires NM; Schepers A; Agema WR; Boesten LS; de Vries MR; Zwinderman AH; de Maat MP; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; 't Hart LM; Frants RR; Quax PH; van Vlijmen BJ; Havekes LM; van der Laarse A; van der Wall EE; Jukema JW
FASEB J; 2005 Dec; 19(14):1998-2004. PubMed ID: 16319143
[TBL] [Abstract][Full Text] [Related]
20. Aspirin resistance and a single gene.
Jefferson BK; Foster JH; McCarthy JJ; Ginsburg G; Parker A; Kottke-Marchant K; Topol EJ
Am J Cardiol; 2005 Mar; 95(6):805-8. PubMed ID: 15757620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
